Loading
The whole lifecycle, verified against the filings.
Rumor → LOI → definitive → approved
Summed over all 1 filed.
More equity than the headline, over all 1 measured.
Too few quarters in this view to draw a cadence.
A definitive agreement is signed and the vote is still ahead, so the redemption right survives to it.
| SPAC | Target | Segment | Value | Announced | Vote | SPAC price | Status | ARS | Delivers | Notes |
|---|---|---|---|---|---|---|---|---|---|---|
| NHICNewHold III | newcleo | Nuclear/Energy | $2.4B | May 27, 2026 | Sep 17, 2026 · 7d | $10.62 | -0.4% | Definitive (DA signed) | 84 |
The list is grouped by lifecycle stage and the sort orders rows inside a stage: a vote that has already passed and one still ahead are not the same list. An announced deal is not a closed deal — 0 of the combinations in our record were terminated. A premium to trust is a selling point, not a buying point — and once a vote has passed there is no redemption right left to price against. Every stage, target and figure here is read from the SEC filing that stated it; where a figure is missing it is missing from our record, and the page says so rather than estimating one.
1 of 1 deals in this view carry a dated vote or a stated close period. Where the Vote column is empty, the filings we hold state neither — that is a gap in our record, not a claim that the parties have no timetable.
Sorted inside each stage.
| F-4/A Aug 2026; $220M PIPE |